Skin cancer is one of the most common cancers in the United States. It affects hundreds of thousands of people every year. Finding skin cancer early and diagnosing it correctly is very important for treatment and better results. The number of skin cancer cases, especially melanoma, is increasing. This causes problems like many patients needing care, long wait times, and a need for more accurate diagnosis tools. New developments in artificial intelligence (AI) and advanced imaging technology are helping by making skin cancer detection faster and more accurate. They also help doctors and clinics work better.
This article explains how AI combined with advanced imaging is changing how skin cancer is found and treated in the United States. It also talks about what this means for medical office managers, healthcare owners, and IT managers who work to put these technologies into clinics.
Skin cancer includes melanoma and other types. It has been increasing in the United States. The Melanoma Research Alliance reported that more than 196,000 melanoma cases were expected in 2020. Thousands of people still die from it even with better treatments. Over the last ten years, melanoma cases have gone up by about 1.5% each year. But death rates have dropped by about 2.9% each year because cases are found earlier.
Traditional ways to find skin cancer include looking at the skin, doing biopsies, and using special tools called dermoscopes. But these methods have problems. Biopsies are accurate but can be painful, expensive, and sometimes done when not needed. Between 2000 and 2015, biopsies in people older than 65 more than doubled. For every 1,000 biopsies, only about 13 melanomas were found. This shows there are many unnecessary biopsies. Here, AI and better imaging can help doctors decide when a biopsy is really needed.
In the last 20 years, more dermatologists in the U.S. have been using imaging devices like dermatoscopes. Some reports say 40% to 80% of dermatologists use them. A dermatoscope is a small device that helps doctors see the skin better. It improves how well they detect melanoma. Other advanced imaging tools include:
These imaging tools help doctors find skin cancer earlier. They also help make better treatment choices and reduce pain and costs for patients.
AI is now an important part of skin cancer diagnosis. It looks at many skin images and helps doctors find cancer more reliably. Groups like the International Skin Imaging Collaboration (ISIC) have collected over 75,000 images to train AI programs for skin care. Every year, contests held by ISIC show that AI keeps getting better at understanding skin images. Sometimes, AI does better than expert doctors in spotting melanoma from pictures.
AI uses deep learning to notice tricky details in skin spots that humans might miss. These tools are made to help doctors, not replace them. AI can highlight spots that need more attention.
Doctors like Dr. Veronica Rotemberg from Memorial Sloan Kettering Cancer Center say AI can help lower the number of biopsies that turn out unnecessary. It also helps find melanoma early. AI can support doctors in predicting how serious the cancer is and choosing the right treatment.
Teledermatology means doctors check skin problems using digital pictures and video from far away. It has grown quickly, especially during and after the COVID-19 pandemic. This way works well for skin cancer because many spots can be seen from the outside.
In England, the National Health Service (NHS) has sped up using teledermatology to find skin cancer faster. About 15% of NHS groups use high-quality images to look at spots remotely. AI tools that can tell if a spot might be cancer in seconds help reduce visits that are not really needed. This idea works well in rural and hard-to-reach places in the U.S. where see a skin specialist is hard.
Dr. Tom While, a UK doctor, says teledermatology helps by making referrals easier and cutting down travel and wait times for patients. U.S. healthcare managers can learn from this when planning to use teledermatology and AI.
Some skin cancers, like amelanotic melanoma (AM), are harder to detect. AM does not have the usual dark color and looks different. Usual rules used by doctors, such as the ABCDE rule (Asymmetry, Border, Color, Diameter, Evolving), and dermoscopy may miss these cases early.
AI combined with high-tech imaging like RCM and OCT can find AM better by spotting small blood vessel and skin pattern changes that doctors might miss. Adding AI with genetic and molecular tests helps doctors figure out how risky the cancer is and choose treatments made for each patient.
Research shows these combined AI systems help doctors tell how advanced the cancer is and predict how well patients will respond to treatment. More testing in clinics is needed, but these new methods seem useful for better skin cancer care.
For medical office managers, healthcare owners, and IT teams, AI helps not just with diagnosis but also with daily work in clinics. It helps handle more patients without tiring out the staff.
By automating simple tasks and improving workflow, AI helps clinics treat more patients accurately and keep patients involved in their care.
Medical office managers and healthcare owners should think about both the benefits and challenges when bringing AI and imaging tools into skin care.
Several groups and experts lead work on AI and skin imaging in the U.S.:
For clinics thinking about using AI and advanced imaging, it helps to take steps slowly:
Using artificial intelligence with advanced skin imaging is changing how skin cancer is diagnosed in the United States. Clinics that use these tools can expect to work more efficiently, diagnose better, and give improved care. These things are important for handling the growing need for skin care today and in the future.
Teledermatology is a method that uses high-resolution imaging technology, such as dermatoscopes, to remotely evaluate skin conditions. It allows dermatologists to review more patients by capturing images of spots, moles, or lesions on patients’ skin, ultimately speeding up diagnosis and treatment.
Teledermatology significantly improves patient care by allowing quicker diagnoses, reducing unnecessary travel for patients, especially in rural areas, and streamlining the referral process to specialists, which collectively helps reduce waiting lists.
AI plays a crucial role by enhancing the precision of skin lesion evaluations. The NHS is trialing AI technology that can assess skin lesions for malignancy, providing faster and more accurate diagnosis alongside clinician assessments.
Advancements include the use of dermatoscopes attached to phone cameras for high-quality imaging and AI-powered magnifying lenses that assist in rapid lesion assessment, ultimately reducing the need for face-to-face appointments.
To address increasing demand, the NHS is expanding teledermatology services across community diagnostic centers, aiming to reduce the time patients wait for skin assessments by allowing direct referrals to local diagnostic hubs.
Hospitals have been urged to aim for a 10-day turnaround for delivering diagnostic test results for urgent cancer referrals, ensuring timely treatment and improving patient outcomes.
Teledermatology has proven successful, with some hospitals diagnosing and treating nearly all skin cancer patients within two months of an urgent referral, thereby enhancing patient care and efficiency in healthcare delivery.
High-resolution imaging allows dermatologists to assess skin conditions with greater accuracy and detail, facilitating early diagnosis and treatment of skin cancer, which can significantly impact patient survival rates.
Public awareness campaigns have led to an increase in GP referrals for cancer, with up to one in four monthly referrals being cancer-related, reflecting a growing recognition of the importance of early diagnosis.
The NHS has significantly reduced waiting times for cancer treatment, decreasing the 62-day backlog by almost 15,000 patients and ensuring that over 90% of patients begin treatment within one month of diagnosis.